🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
How to predict which patients with initially unresectable liver cancer are ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10-01
Trial ID
NCT07716345
Treatments Being Tested
Pancreatic ductal adenocarcinoma (PDAC), representing 85-95% of pancreatic ...
Status
Recruiting
Location
Shengjing hospital of China medical university
Start Date
2020-10-09
Trial ID
NCT06849063
Treatments Being Tested
Microscopic residual tumor at the resection margin is a critical risk facto...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-01
Trial ID
NCT07704216
Treatments Being Tested
This prospective single-center study aims to evaluate the feasibility and c...
Status
Recruiting
Location
Shengjing Hospital
Start Date
2022-10-19
Trial ID
NCT06955208
Treatments Being Tested
To construct a novel, non-invasive, accurate, and convenient method to achi...
Status
Recruiting
Location
Shengjing Hospital of China Medical University
Start Date
2022-06-14
Trial ID
NCT06463366
Treatments Being Tested
How to construct a novel, non-invasive, accurate, and convenient method to ...
Status
Recruiting
Location
Shengjing Hospital
Start Date
2022-08-16
Trial ID
NCT05475015
How to accurately and safely evaluate regional liver function before hepate...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-01
Trial ID
NCT07704203
Treatments Being Tested
How to construct a novel, non-invasive, accurate, and convenient method to ...
Status
Recruiting
Location
Shengjing Hospital of China Medical University
Start Date
2022-08-16
Trial ID
NCT06205992
Pancreatic ductal adenocarcinoma (PDAC) accounts for 85-95% of pancreatic c...
Status
Recruiting
Location
Shengjing hospital of china medical university
Start Date
2020-10-09
Trial ID
NCT06526442
Treatments Being Tested